BOTANNIS LABS NY INC. RECEIVES ZERO OBSERVATIONS DURING U.S. FDA FACILITY INSPECTION
HAUPPAUGE, N.Y., July 19, 2023 (Newswire.com) – Botannis Labs NY Inc. is delighted to announce the successful completion of a facility inspection by the U.S. Food and Drug Administration (FDA), the leading regulatory body overseeing the nutraceutical and pharmaceutical industries. The successful inspection validates Botannis’ commitment to delivering exceptional analytical testing services. This was a routine […]